1. Home
  2. RNXT vs EDRY Comparison

RNXT vs EDRY Comparison

Compare RNXT & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • EDRY
  • Stock Information
  • Founded
  • RNXT 2012
  • EDRY 2018
  • Country
  • RNXT United States
  • EDRY Greece
  • Employees
  • RNXT N/A
  • EDRY N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • EDRY Marine Transportation
  • Sector
  • RNXT Health Care
  • EDRY Consumer Discretionary
  • Exchange
  • RNXT Nasdaq
  • EDRY Nasdaq
  • Market Cap
  • RNXT 44.0M
  • EDRY 36.5M
  • IPO Year
  • RNXT 2021
  • EDRY N/A
  • Fundamental
  • Price
  • RNXT $1.11
  • EDRY $12.91
  • Analyst Decision
  • RNXT Strong Buy
  • EDRY
  • Analyst Count
  • RNXT 2
  • EDRY 0
  • Target Price
  • RNXT $7.50
  • EDRY N/A
  • AVG Volume (30 Days)
  • RNXT 552.5K
  • EDRY 3.3K
  • Earning Date
  • RNXT 11-13-2025
  • EDRY 11-18-2025
  • Dividend Yield
  • RNXT N/A
  • EDRY N/A
  • EPS Growth
  • RNXT N/A
  • EDRY N/A
  • EPS
  • RNXT N/A
  • EDRY N/A
  • Revenue
  • RNXT $662,000.00
  • EDRY $49,707,775.00
  • Revenue This Year
  • RNXT $2,895.35
  • EDRY N/A
  • Revenue Next Year
  • RNXT $313.04
  • EDRY $20.65
  • P/E Ratio
  • RNXT N/A
  • EDRY N/A
  • Revenue Growth
  • RNXT N/A
  • EDRY N/A
  • 52 Week Low
  • RNXT $0.75
  • EDRY $7.60
  • 52 Week High
  • RNXT $1.69
  • EDRY $18.47
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 46.69
  • EDRY 64.24
  • Support Level
  • RNXT $0.98
  • EDRY $11.95
  • Resistance Level
  • RNXT $1.15
  • EDRY $13.00
  • Average True Range (ATR)
  • RNXT 0.09
  • EDRY 0.23
  • MACD
  • RNXT -0.01
  • EDRY 0.03
  • Stochastic Oscillator
  • RNXT 39.99
  • EDRY 91.47

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About EDRY EuroDry Ltd.

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.

Share on Social Networks: